Αρχική World News Researchers Discover Genetic Marker That Increases Risk Of Premenopausal Breast Cancer

Researchers Discover Genetic Marker That Increases Risk Of Premenopausal Breast Cancer

Scientists have found that a variant of the genetic marker rs1429142 is responsible for causing an increased risk of breast cancer in Caucasian women compared to women who don’t have the variant.It’s the first study of its kind to compare breast cancer risk between premenopausal Caucasian women and postmenopausal Caucasian women. Most genetic studies focus on postmenopausal women alone. After all, most breast cancers are diagnosed in women who are over 55 years old. But inherited forms of breast cancer — which are often linked to genetic mutations — tend to be more aggressive and are typically diagnosed at a younger age.“Finding this genetic marker is like starting with a high-resolution Google map of the world, and then slowly zooming in to the image of your house,” researcher Sambasivarao Damaraju said. “It is valuable to do because now we have essentially planted a road sign on the chromosome that can help future researchers to carry out further in-depth studies.”Photo: Adobe Stock/catalin
The study was published in the International Journal of Cancer and led by Sambasivarao Damaraju, a professor at the University of Alberta’s Department of Laboratory Medicine & Pathology. He’s also a member of the Cancer Research Institute of Northern Alberta.Damaraju and his team studied over 9,000 women from Alberta for the study, some of whom had been diagnosed with breast cancer and some who served as healthy controls. Using the participants’ DNA gathered from blood samples, the team found that rs1429142 consistently cropped up in association with elevated breast cancer risk.Photo: Adobe Stock/andreaobzerova
When they separated the data by menopausal status, the difference in risk was significant. Premenopausal women had a 40% higher risk than postmenopausal women.The team took what they learned in this study and also looked at the gene’s impact on women of Chinese and African descent. They found that rs1429142 was associated with premenopausal breast cancer risk in women of African descent, but not women of Chinese descent.While researchers were focused primarily on the rs1429142 gene for this study, they did find that there were other genetic variants that were also associated with premenopausal breast cancer risk that require further research.Photo: Adobe Stock/phonlamaiphoto
The more genes scientists discover that affect breast cancer risk, the more tools doctors will have at their disposal to help people who are at increased risk for the disease.“This is important because the more we are able to create a complete picture of all the genes and all the variations and mutations that contribute to breast cancer, the closer we get to developing a genetic screen for breast cancer on a population level,” said Damaraju. “If we can identify women at risk before they are diagnosed, and as long as we have the resources to mitigate that risk through preventative approaches, we can reduce the overall burden of breast cancer risk in a population.”Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Foodie Friday: It’s Berry Season!

July is National Berry Month! If berries aren’t part of your daily diet, now is the perfect time to start eating more of these...

No Link Between Viral Vector in Zynteglo and Acute Myeloid Leukaemia

On 23 July 2021, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) has endorsed findings of...

Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home

A woman was 9 months pregnant when she found a pregnant stray cat. Unable to bear the thought of the fellow mom giving birth...

3 Questions Cancer Caregivers Can Ask Themselves to Help Prevent Burnout

Karen Warner Schueler is the president of her own executive coaching firm and author of The Sudden Caregiver: A Roadmap for Resilient Caregiving. For...

FDA Approval of Rylaze Will Address Drug Shortage for Childhood ALL

July 29, 2021, by NCI Staff FDA's approval of Rylaze is expected to help address a long-running shortage of the drug Erwinia asparaginase for kids...

EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib

On 22 July 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...